Literature DB >> 32335513

Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis.

Ennio Giulio Favalli1, Elena Agape2, Roberto Caporali3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32335513     DOI： 10.3899/jrheum.200507

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  36 in total

1.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2020-06-27       Impact factor: 9.079

2.  Clinical course of idiopathic inflammatory myopathies in COVID-19 pandemic: a single-center experience.

Authors:  Hakan Apaydin; Abdulsamet Erden; Serdar C Güven; Berkan Armağan; Özlem Karakaş; Bahar Özdemir; Bünyamin Polat; Mehmet Akif Eksin; Ahmet Omma; Orhan Kucuksahin
Journal:  Future Virol       Date:  2022-06-15       Impact factor: 3.015

3. 

Authors:  Luca Quartuccio; Francesca Valent; Enrico Pasut; Carlo Tascini; Salvatore De Vita
Journal:  Rev Rhum Ed Fr       Date:  2021-05-14

Review 4.  Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review.

Authors:  Ilke Coskun Benlidayi; Behice Kurtaran; Emre Tirasci; Rengin Guzel
Journal:  Rheumatol Int       Date:  2020-06-26       Impact factor: 2.631

Review 5.  COVID-19 in Immunocompromised Hosts: What We Know So Far.

Authors:  Monica Fung; Jennifer M Babik
Journal:  Clin Infect Dis       Date:  2021-01-27       Impact factor: 20.999

6.  Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.

Authors:  Xabier Michelena; Helena Borrell; Mireia López-Corbeto; María López-Lasanta; Estefanía Moreno; María Pascual-Pastor; Alba Erra; Mayte Serrat; Esther Espartal; Susana Antón; Gustavo Adolfo Añez; Raquel Caparrós-Ruiz; Andrea Pluma; Ernesto Trallero-Araguás; Mireia Barceló-Bru; Miriam Almirall; Juan José De Agustín; Jordi Lladós; Antonio Julià; Sara Marsal
Journal:  Semin Arthritis Rheum       Date:  2020-05-16       Impact factor: 5.532

Review 7.  Autoimmunity as the comet tail of COVID-19 pandemic.

Authors:  Rossella Talotta; Erle Robertson
Journal:  World J Clin Cases       Date:  2020-09-06       Impact factor: 1.337

8.  Incidence of COVID-19 in Patients With Rheumatic Diseases Treated With Targeted Immunosuppressive Drugs: What Can We Learn From Observational Data?

Authors:  Ennio Giulio Favalli; Sara Monti; Francesca Ingegnoli; Silvia Balduzzi; Roberto Caporali; Carlomaurizio Montecucco
Journal:  Arthritis Rheumatol       Date:  2020-09-06       Impact factor: 15.483

9.  Predictors of hospitalization for COVID-19 in patients with autoimmune rheumatic diseases: results from a community cohort follow-up.

Authors:  Rocío-V Gamboa-Cárdenas; Silvia Barzola-Cerrón; Denisse Toledo-Neira; Cristina Reátegui-Sokolova; Víctor Pimentel-Quiroz; Francisco Zevallos-Miranda; Graciela S Alarcón; Manuel Ugarte-Gil
Journal:  Clin Rheumatol       Date:  2021-06-30       Impact factor: 2.980

10.  Cutaneous autoimmune diseases during COVID-19 pandemic.

Authors:  C Günther; R Aschoff; S Beissert
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-02       Impact factor: 9.228
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.